TKCI outlines plan to curb corneal blindness worldwide by 2030

The Tej Kohli Cornea Institute (TKCI) in partnership with the world-renowned LV Prasad Eye Institute (LVPEI), has today laid out its plan to control corneal blindness, globally, by 2030. This is a five year acceleration from previous estimates and one which will substantially alleviate the impact on economic growth in developing countries that sight impairment causes.

Corneal blindness is responsible for 4.9 million of the 39 million blind people in the world and is the third major cause of blindness after cataract and glaucoma. The Tej Kohli Foundation has long been committed to a programme of corneal education and care in India and its partnership with the LVPEI to form TKCI is part of a strategy to accelerate this in India and then globally.

Since the TKCI was founded in December 2015, with an injection of USD 10 million funding from the Tej Kohli Foundation, it has completed 2,000 successful corneal operations in India, including over 1,000 corneal transplants. Following its early success, the TKCI has been invited to review corneal services in Oman and assist them with restarting corneal transplants.

Tej Kohli, Chairman of Kohli Ventures and Founder of the Tej Kohli Foundation said:

Alongside world-class technology and expertise, we now have a programme of education and training, eye research, product development and a global network of resource centres, which makes it possible to extend our vision to control corneal blindness across the globe by 2030.

Pravin Vaddavalli, Director, Tej Kohli Cornea Institute, said:

Corneal blindness and diseases causing it have been on the radar of corneal surgeons for years but with the focus and funding brought in by TKCI, controlling needless blindness by 2030 has for the first time, started to sound like a reality.

The TKCI and LVPEI are developing a network of cornea institutes regionally and eventually around the world which will work together to control corneal blindness. The strategy will encompass direct impact through service delivery and education, and indirect impact through education, research, models, advocacy, plans and policy.

Phase 1 (2 years)

  • Upgrading and doubling of capacity in all of the LVPEI’s four academic/tertiary care campuses in, patient care, education and research
  • Explore and harness technology in the field of cornea disease and blindness
  • Assess the magnitude of the problem in areas of impact

Phase 2 (2-8 years)

  • Network of cornea centres in India and internationally
  • Four regional centres in India
  • 10 international centres
  • Help in the development of cornea units in medical colleges

Research & education innovation (throughout Phase 1 & 2 and beyond)

  • New techniques of stem cell therapy
  • Effective control of corneal infections
  • Eye banking model for developing countries
  • Technology transfer to corneal preservation media
  • Training eye care professionals in the care of corneal transplants
  • Primary and secondary eye care interventions for corneal problems
  • Corneal transplants in children
  • Comprehensive care of end stage of corneal disease
  • Preventive strategies at the primary level

Source: http://tejkohlifoundation.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-READI consortium launches groundbreaking diabetes data study